2026 Pankind Pancreatic Cancer Research Foundation Grants

Funding streams and amounts:
- Early Detection Accelerator Grant ($300,000 for 2 years)
- New Treatment Innovation Grant ($100,000 for 1 year)
- New Treatment Accelerator Grant ($300,000 for 2 years).
Applications close: August 14 202

PanKind has launched its 12th annual 2026 Pankind Competitive Grant Round to fund Australian pancreatic cancer research across two priority areas, Early Detection and New Treatments. The round offers three categories: the Early Detection Accelerator Grant ($300,000 over 2 years), the New Treatment Innovation Grant ($100,000 over 1 year), and the New Treatment Accelerator Grant ($300,000 over 2 years).

Key Requirements

Alignment to the round’s focus areas: Projects must address Early Detection or New Treatments for pancreatic cancer, with applications submitted under the relevant grant category.
Project maturity expectations (category-dependent): Accelerator categories are intended for developed projects beyond proof-of-concept, with clear advancement toward clinical application.
Funding overlap transparency: Applicants must disclose any potential overlap with other current or pending research funding.
Eligibility controls on submissions: Only one application per institution may be submitted for each scheme, and a Principal Investigator may be named on no more than one application across all categories in the same round.
Australia-based delivery: The Principal Investigator must be based in Australia and the administering institution must be an Australian organisation.
Governance for human materials or data: Where human biospecimens or data are involved, a supporting letter from an appropriate and accessible repository or collection is required at application, and ethics and governance status and pathways must be clearly outlined

What is eligible for funding?

Conduct developed early detection projects that advance methods toward clinical validation or implementation, including work that accelerates translation from laboratory to clinical studies or practice.
Advance detection strategies toward clinical application, including biomarker development, imaging tools, or risk stratification approaches, where aligned to the category intent.
Explore early-stage, innovative projects to develop new treatments, diagnostics, or quality-of-care improvements, including feasibility and proof-of-concept work to reach key inflection points.
Progress developed new treatment projects to accelerate translation to a clinical stage, including extending or scaling existing work and advancing critical milestones

What companies are eligible for funding?

Australian-based Principal Investigators applying through an Australian administering institution.
Biotechnology, pharmaceutical, and other commercial entities may apply, with funding terms potentially varied for successful commercial applicants.
Applicants must meet submission limits across the round, including institution and investigator application caps described on the grant page.

Is this grant competitive or entitlement based?

Competitive. Your application will be assessed among other applications by a judging panel.

How can I increase my chances of winning this grant?

By engaging an accredited government grants consultant, such as Avant Group.

Competitive grants often require significant business case development and project analysis to support the application, this may include detailed presentations supporting the project’s merit, projected sales, cost-benefit analysis and more.

As part of your engagement with Avant Group, your account manager will assess the required documents and will provide the following as needed to support your grant submission.

Grant application writeup including a detailed presentation illustrating how the grant funding will contribute to your project, how the funding will contribute to the project’s budget, a project milestone plan, delivery timeline, impact on employment if applicable and a breakdown of the management and leadership team for the project

Industry analysis presentation
Competitor Analysis Presentation
Marketing and Sales Analysis Presentation
3-5 year Cashflow Forecast
3-5 year Balance Sheet Forecast
Cost-Benefit Analysis of Grant Funding
End-to-end grant application including information collating, analysis and application writing
CAPEX (Capital Expenditure) cost-benefit analysis
Stakeholder relations and Risk Mitigation Plans
Any other relevant forecasting that will support your application

How can I get help with my application? Or know if I’m likely to win funding?

Avant Group offers a no-obligation assessment of your eligibility for funding and will assess your likelihood of a successful grant application.

This grant is open

Apply for this grant below:

OR